domingo, 22 de diciembre de 2019

Aducanumab isn't the simple solution to the Alzheimer's crisis - STAT

Aducanumab isn't the simple solution to the Alzheimer's crisis - STAT

First Opinion

Aducanumab isn’t the simple solution to the complicated Alzheimer’s crisis

By JASON KARLAWISH


SEBASTIEN BOZON/AFP VIA GETTY IMAGES
What if we could treat Alzheimer's-related mild cognitive impairment with a somewhat effective but costly and risky drug? The answers are discomforting.

No hay comentarios: